ASB15

gene
On this page

Also known as FLJ43370

Summary

ASB15 (ankyrin repeat and SOCS box containing 15, HGNC:19767) is a protein-coding gene on chromosome 7q31.32, encoding Ankyrin repeat and SOCS box protein 15 (Q8WXK1). May be a substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins.

This gene encodes a member of the suppressor of cytokine signaling box superfamily. The proteins in this superfamily participate in the ubiquitin-proteasome system for the degradation of proteins in the cell cycle and signal transduction pathways. Alternative splicing results in multiple transcript variants.

Source: NCBI Gene 142685 — RefSeq curated summary.

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 91 total
  • MANE Select transcript: NM_001290258

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:19767
Approved symbolASB15
Nameankyrin repeat and SOCS box containing 15
Location7q31.32
Locus typegene with protein product
StatusApproved
AliasesFLJ43370
Ensembl geneENSG00000146809
Ensembl biotypeprotein_coding
OMIM619757
Entrez142685

Gene structure

Transcript identifiers

Ensembl transcripts: 53 — 53 protein_coding

ENST00000275699, ENST00000434204, ENST00000437535, ENST00000447789, ENST00000451215, ENST00000451558, ENST00000883309, ENST00000883310, ENST00000883311, ENST00000883312, ENST00000883313, ENST00000883314, ENST00000883315, ENST00000883316, ENST00000883317, ENST00000883318, ENST00000883319, ENST00000883320, ENST00000883321, ENST00000883322, ENST00000883323, ENST00000883324, ENST00000883325, ENST00000883326, ENST00000883327, ENST00000883328, ENST00000944011, ENST00000944012, ENST00000944013, ENST00000944014, ENST00000944015, ENST00000944016, ENST00000944017, ENST00000944018, ENST00000944019, ENST00000944020, ENST00000944021, ENST00000944022, ENST00000944023, ENST00000944024, ENST00000944025, ENST00000944026, ENST00000944027, ENST00000944028, ENST00000944029, ENST00000944030, ENST00000944031, ENST00000944032, ENST00000944033, ENST00000944034, ENST00000944035, ENST00000944036, ENST00000944037

RefSeq mRNA: 2 — MANE Select: NM_001290258 NM_001290258, NM_080928

CCDS: CCDS34742

Canonical transcript exons

ENST00000451215 — 12 exons

ExonStartEnd
ENSE00000977399123627110123627281
ENSE00001086542123628864123629434
ENSE00001136383123629966123630119
ENSE00001384078123624569123624814
ENSE00001592803123608594123608654
ENSE00001621957123636809123639481
ENSE00001743353123604032123604212
ENSE00001748037123601821123601914
ENSE00003712008123614501123614609
ENSE00003719759123616221123616273
ENSE00003743403123617579123617737
ENSE00003787794123616364123616495

Expression profiles

Bgee: expression breadth broad, 68 present calls, max score 91.21.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2240 / max 43.4780, expressed in 34 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
808510.099127
808520.066226
2046760.058724

Top tissues by expression

216 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
hindlimb stylopod muscleUBERON:000425291.21gold quality
apex of heartUBERON:000209888.54gold quality
muscle of legUBERON:000138385.74gold quality
gastrocnemiusUBERON:000138885.74gold quality
heart left ventricleUBERON:000208484.57gold quality
cardiac ventricleUBERON:000208283.76gold quality
skeletal muscle tissue of rectus abdominisUBERON:000451183.64gold quality
right atrium auricular regionUBERON:000663182.13gold quality
cardiac atriumUBERON:000208181.42gold quality
skeletal muscle tissueUBERON:000113481.35gold quality
vastus lateralisUBERON:000137981.01gold quality
quadriceps femorisUBERON:000137780.75gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047379.84gold quality
heartUBERON:000094877.11gold quality
skeletal muscle tissue of biceps brachiiUBERON:000450276.02silver quality
muscle tissueUBERON:000238575.07gold quality
biceps brachiiUBERON:000150774.53silver quality
deltoidUBERON:000147670.33gold quality
spermCL:000001965.16silver quality
buccal mucosa cellCL:000233662.46gold quality
heart right ventricleUBERON:000208062.22silver quality
endothelial cellCL:000011560.98gold quality
adult mammalian kidneyUBERON:000008258.06gold quality
myocardiumUBERON:000234957.83gold quality
body of tongueUBERON:001187657.15silver quality
gingival epitheliumUBERON:000194957.08gold quality
seminal vesicleUBERON:000099856.18gold quality
amniotic fluidUBERON:000017355.42gold quality
gingivaUBERON:000182855.36gold quality
tongueUBERON:000172355.26silver quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-GEOD-75367no14.09
E-ANND-3no4.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

68 targeting ASB15, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-432-3P100.0067.86705
HSA-MIR-5011-5P100.0083.465820
HSA-MIR-607799.9968.042299
HSA-MIR-548P99.9872.253784
HSA-MIR-6793-5P99.9765.95758
HSA-MIR-551B-5P99.9671.283493
HSA-MIR-23A-3P99.9574.243163
HSA-MIR-23B-3P99.9574.243163
HSA-MIR-23C99.9573.923192
HSA-MIR-130599.9171.433443
HSA-MIR-548AR-3P99.8571.263889
HSA-MIR-442099.8270.081624
HSA-MIR-548AZ-3P99.8270.563549
HSA-MIR-548BC99.8270.613524
HSA-MIR-548E-3P99.8270.593514
HSA-MIR-548F-3P99.8270.593540
HSA-MIR-449599.8272.083080
HSA-MIR-313399.8170.923506
HSA-MIR-181B-2-3P99.8170.061646
HSA-MIR-181B-3P99.8170.061646
HSA-MIR-548A-3P99.7670.583524
HSA-MIR-498-5P99.7669.641807
HSA-MIR-3617-5P99.7569.411968
HSA-MIR-64199.7569.351975
HSA-MIR-361899.6968.571012
HSA-MIR-466399.6265.33957
HSA-MIR-4762-5P99.5768.541424
HSA-MIR-467299.5071.582893
HSA-MIR-444199.4966.563216
HSA-MIR-431199.3170.473041

Literature-anchored findings (GeneRIF, showing 3)

  • ASB15 gene, consisting of 12 exons, was identified by using bio-informatics. (PMID:16012773)
  • The apparent occurrence of an unusual TG 3’ splice site in intron 9 is critically discussed. (PMID:17672918)
  • Genome-wide association study reveals two novel risk alleles for incident obstructive sleep apnea in the EPISONO cohort. (PMID:31786426)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_rerioasb15aENSDARG00000045633
danio_rerioasb15bENSDARG00000045863
mus_musculusAsb15ENSMUSG00000029685
rattus_norvegicusAsb15ENSRNOG00000006365

Paralogs (7): ASB4 (ENSG00000005981), ASB3 (ENSG00000115239), ASB10 (ENSG00000146926), ASB16 (ENSG00000161664), ASB18 (ENSG00000182177), MPHOSPH8 (ENSG00000196199), ASB14 (ENSG00000239388)

Protein

Protein identifiers

Ankyrin repeat and SOCS box protein 15Q8WXK1 (reviewed: Q8WXK1)

All UniProt accessions (4): Q8WXK1, A0A0C4DG46, A0A384NYV2, C9J956

UniProt curated annotations — full annotation on UniProt →

Function. May be a substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins.

Domain organisation. The SOCS box domain mediates the interaction with the Elongin BC complex, an adapter module in different E3 ubiquitin-protein ligase complexes.

Pathway. Protein modification; protein ubiquitination.

Similarity. Belongs to the ankyrin SOCS box (ASB) family.

RefSeq proteins (2): NP_001277187, NP_563616 (=MANE)

Domains & families (InterPro)

IDNameType
IPR001496SOCS_boxDomain
IPR002110Ankyrin_rptRepeat
IPR036036SOCS_box-like_dom_sfHomologous_superfamily
IPR036770Ankyrin_rpt-contain_sfHomologous_superfamily

Pfam: PF07525, PF12796, PF13606

UniProt features (14 total): repeat 9, sequence variant 2, chain 1, domain 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8WXK1-F187.390.70

Function

Pathways and Gene Ontology

Reactome pathways

7 pathways

IDPathway
R-HSA-8951664Neddylation
R-HSA-983168Antigen processing: Ubiquitination & Proteasome degradation
R-HSA-1280218Adaptive Immune System
R-HSA-168256Immune System
R-HSA-392499Metabolism of proteins
R-HSA-597592Post-translational protein modification
R-HSA-983169Class I MHC mediated antigen processing & presentation

MSigDB gene sets: 74 (showing top): GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_DN, REACTOME_ADAPTIVE_IMMUNE_SYSTEM, REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION, REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION, GCANCTGNY_MYOD_Q6, CAGCAGG_MIR370, GOBP_POST_TRANSLATIONAL_PROTEIN_MODIFICATION, MYOD_Q6, CUI_TCF21_TARGETS_2_DN, CAGCCTC_MIR4855P, chr7q31, REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION, MIKKELSEN_ES_ICP_WITH_H3K4ME3, MIKKELSEN_NPC_ICP_WITH_H3K4ME3, WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D

GO Biological Process (2): protein ubiquitination (GO:0016567), intracellular signal transduction (GO:0035556)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (1): cytosol (GO:0005829)

Reactome top-level categories

Rollup of top-5 pathways:

CategoryPathways
Post-translational protein modification1
Class I MHC mediated antigen processing & presentation1
Immune System1
Metabolism of proteins1
Adaptive Immune System1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
protein modification by small protein conjugation1
intracellular anatomical structure1
signal transduction1
binding1
cytoplasm1
cellular anatomical structure1

Protein interactions and networks

STRING

1218 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ASB15LMOD2Q6P5Q4497
ASB15IQUBQ8NA54492
ASB15SLC13A1Q9BZW2491
ASB15WDR49Q8IV35475
ASB15KAAG1Q9UBP8474
ASB15PLEKHH3Q7Z736454
ASB15NDUFA5Q16718433
ASB15ASB6Q9NWX5431
ASB15CISHQ9NSE2421
ASB15KLHL13Q9P2N7419
ASB15CBY3A6NI87413
ASB15GRIFINA4D1Z8409
ASB15SAXO1Q8IYX7387
ASB15ASB4Q9Y574386
ASB15IFT70AQ86WT1380

IntAct

41 interactions, top by confidence:

ABTypeScore
KANK2ASB15psi-mi:“MI:0915”(physical association)0.560
LMO1ASB15psi-mi:“MI:0915”(physical association)0.560
PRPF31ASB15psi-mi:“MI:0915”(physical association)0.560
CCDC13ASB15psi-mi:“MI:0915”(physical association)0.560
ASB15ZNF587psi-mi:“MI:0915”(physical association)0.560
PRR35ASB15psi-mi:“MI:0915”(physical association)0.560
MGC50722ASB15psi-mi:“MI:0915”(physical association)0.560
ZFYVE26ASB15psi-mi:“MI:0915”(physical association)0.560
GEMASB15psi-mi:“MI:0915”(physical association)0.560
ASB15GPSM3psi-mi:“MI:0915”(physical association)0.560
USHBP1ASB15psi-mi:“MI:0915”(physical association)0.560
KRT75ASB15psi-mi:“MI:0915”(physical association)0.560
HDAC4ASB15psi-mi:“MI:0915”(physical association)0.560
Ppsi-mi:“MI:0914”(association)0.350
KANK2ASB15psi-mi:“MI:0915”(physical association)0.000
HDAC4ASB15psi-mi:“MI:0915”(physical association)0.000
ZFYVE26ASB15psi-mi:“MI:0915”(physical association)0.000
GEMASB15psi-mi:“MI:0915”(physical association)0.000
GPSM3ASB15psi-mi:“MI:0915”(physical association)0.000
USHBP1ASB15psi-mi:“MI:0915”(physical association)0.000
LMO1ASB15psi-mi:“MI:0915”(physical association)0.000
PRPF31ASB15psi-mi:“MI:0915”(physical association)0.000
CCDC13ASB15psi-mi:“MI:0915”(physical association)0.000
ZNF587ASB15psi-mi:“MI:0915”(physical association)0.000
PRR35ASB15psi-mi:“MI:0915”(physical association)0.000
MGC50722ASB15psi-mi:“MI:0915”(physical association)0.000

BioGRID (33): ASB15 (Two-hybrid), ASB15 (Two-hybrid), ASB15 (Two-hybrid), ASB15 (Two-hybrid), PRR35 (Two-hybrid), GEM (Two-hybrid), LMO1 (Two-hybrid), KRT75 (Two-hybrid), KANK2 (Two-hybrid), ZNF587 (Two-hybrid), GPSM3 (Two-hybrid), CCDC13 (Two-hybrid), MGC50722 (Two-hybrid), ASB15 (Affinity Capture-MS), CUL5 (Affinity Capture-MS)

ESM2 similar proteins: A0JM56, A0JPI9, A2BFL2, A5PK13, A6H639, J9SQF3, O13066, P19686, P33402, Q02108, Q0VAA2, Q14BP6, Q15111, Q15813, Q3USB7, Q498T9, Q4R642, Q4V8D9, Q4ZHS0, Q5DU41, Q5FVQ9, Q5RAG3, Q5RBD9, Q5RJH2, Q5ZIJ9, Q5ZIU8, Q62688, Q68F79, Q6DN12, Q6GQN5, Q6NU09, Q6P9F7, Q6WRX3, Q7Z7L7, Q80ZJ6, Q8BG40, Q8CDU4, Q8CIR4, Q8CIV8, Q8HXA6

Diamond homologs: A2RUV0, A6NK59, O35516, P0C927, Q04721, Q3SX45, Q58CT0, Q5U2S6, Q8C6Y6, Q8HXA6, Q8K0L0, Q8VHS6, Q8WXK1, Q96Q27, Q9QW30, A2ARS0, C9JTQ0, Q3KP44, Q9W0T5, A6QR20, P20749, Q08DV6, Q4FE45, Q6KAE5, Q6NLQ8, Q7M6U3, Q9BQI6, Q9WV72, Q9Y575, Q9Z2F6, A2RT91, Q3V096, Q7Z5J8, Q8N9B4, Q9WV74, Q9Y576, Q9P2R3, Q9J519, A0A0R4IQZ2, A2AQH4

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

91 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance84
Likely benign4
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1762 predictions. Top by Δscore:

VariantEffectΔscore
7:123616491:GGATG:Gdonor_gain1.0000
7:123616492:GATGG:Gdonor_gain1.0000
7:123624556:A:AGacceptor_gain1.0000
7:123624557:A:Gacceptor_gain1.0000
7:123624566:A:AGacceptor_gain1.0000
7:123624566:AAGCT:Aacceptor_gain1.0000
7:123624567:A:Gacceptor_gain1.0000
7:123624568:GCT:Gacceptor_gain1.0000
7:123624813:AGGTA:Adonor_loss1.0000
7:123624815:G:GGdonor_gain1.0000
7:123624816:T:Adonor_loss1.0000
7:123627105:GCCA:Gacceptor_loss1.0000
7:123627106:CCAGG:Cacceptor_loss1.0000
7:123627279:TCT:Tdonor_gain1.0000
7:123627280:CTG:Cdonor_loss1.0000
7:123627281:TGT:Tdonor_loss1.0000
7:123627282:G:GGdonor_gain1.0000
7:123627282:GTGA:Gdonor_loss1.0000
7:123627283:T:Gdonor_loss1.0000
7:123627284:G:GCdonor_loss1.0000
7:123627286:G:Cdonor_loss1.0000
7:123628862:A:AGacceptor_gain1.0000
7:123628863:G:GGacceptor_gain1.0000
7:123629230:T:Gacceptor_gain1.0000
7:123614489:A:AGacceptor_gain0.9900
7:123614490:A:Gacceptor_gain0.9900
7:123614494:T:Gacceptor_gain0.9900
7:123614495:A:AGacceptor_gain0.9900
7:123614495:AT:Aacceptor_gain0.9900
7:123614496:T:Gacceptor_gain0.9900

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000037413 (7:123583351 G>A), RS1000061682 (7:123599846 G>T), RS1000093336 (7:123617173 T>G), RS1000115003 (7:123599507 TC>T), RS1000176521 (7:123625655 A>G), RS1000181955 (7:123600418 G>C), RS1000209286 (7:123618696 T>C), RS1000295772 (7:123605974 A>C), RS1000376802 (7:123623312 A>G), RS1000529942 (7:123575363 T>A,C,G), RS1000532378 (7:123605407 A>C,G), RS1000638025 (7:123599282 A>G), RS1000641385 (7:123594858 G>C,T), RS1000706543 (7:123600732 G>A), RS1000717121 (7:123568524 G>A,T)

Disease associations

OMIM: gene MIM:619757 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST004719_2Left ventricular obstructive tract defect (inherited effect)2.000000e-06
GCST006231_33Mean arterial pressure7.000000e-06

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0006340mean arterial pressure

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

8 total (human), top 8 by PubMed support.

ChemicalActions (top 5)PubMed papers
titanium dioxideincreases expression1
sodium arseniteincreases expression1
CGP 52608affects binding, increases reaction1
theaflavin-3,3’-digallateaffects expression1
Resveratrolaffects cotreatment, decreases expression1
Doxorubicindecreases expression1
Plant Extractsaffects cotreatment, decreases expression1
Tobacco Smoke Pollutionincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): congenital left-sided heart lesions